Get ready for the 2026 flu season! Australia's Chief Medical Officer, Professor Michael Kidd, is urging healthcare professionals to emphasize the importance of annual flu vaccinations. In a recent letter, Professor Kidd highlighted the significant impact of healthcare professionals' recommendations on vaccination rates, which have been on a downward trend. He emphasized that a simple endorsement from a trusted doctor or pharmacist can make a huge difference in a patient's decision to get vaccinated. But here's where it gets controversial... Some experts argue that while flu vaccines are essential, the focus should also be on other preventive measures like good hygiene practices and social distancing. What do you think? Will you be getting your flu shot this year? Share your thoughts in the comments!
According to Professor Kidd, the 2026 flu vaccines have been updated with two new A strains, and the National Immunisation Program (NIP) vaccines will be available for order starting April 2026. The manufacturer, CSL Seqirus, has already released its flu vaccines, which are now available for clinics and pharmacies. Dr. Jules Bayliss, the ANZ Vaccines Medical Director for CSL Seqirus, assures that they will be providing early and reliable vaccine supplies to support doctors and pharmacists in their vaccination efforts. This year, CSL Seqirus will be offering both cell-based and adjuvanted vaccines for the private market and as part of the NIP, ensuring that all Australians have access to tailored influenza vaccines.
In the EU, things are getting even more exciting! The European Medicines Agency's drug advisory panel has recommended marketing authorization for Moderna's mCOMBRIAX, the world's first combination flu and COVID mRNA vaccine. This groundbreaking development has the potential to simplify the vaccination process and improve health outcomes. Moderna's CEO, Stephane Bancel, expressed his enthusiasm, stating that this recommendation marks a significant milestone for respiratory virus vaccination and for Moderna itself. If approved, it will be Moderna's fourth marketed product in Europe. But this is where it gets thought-provoking... Some argue that combination vaccines might raise concerns about safety and effectiveness. What's your take on this? Will you be willing to try this new vaccine technology? Let's discuss and explore the pros and cons in the comments section!
